Vertex Pharmaceuticals OverviewVertex Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for VRTX.
Quarterly Other Income/Expense
$114.80M
↑ 14.46% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$427.00M
↓ 3.42% YoY
Trailing 12 months ending Mar 31, 2026